AK
Ashwin Kumar Veeramally
About Ashwin Kumar Veeramally
Data last updated:
Ashwin Kumar Veeramally has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Sri Pranava Gayathri Drugs Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Sri Pranava Gayathri Drugs Private Limited at ₹25.06 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sri Pranava Gayathri Drugs Private Limited U24232TG2008PTC057773 | Director | 21 Apr 2009 | 2008 | ₹25.06 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashwin Kumar Veeramally
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashwin Kumar Veeramally
Ashwin Kumar Veeramally has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Sri Pranava Gayathri Drugs Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Sri Pranava Gayathri Drugs Private Limited at ₹25.06 Cr (FY 2024).
Ashwin Kumar Veeramally is associated with 1 company as Director, including Sri Pranava Gayathri Drugs Private Limited (₹25.06 Cr).
Ashwin Kumar Veeramally has expertise in General Business.
Ashwin Kumar Veeramally has 17 years in corporate governance.
By reported revenue, the largest current company of Ashwin Kumar Veeramally is Sri Pranava Gayathri Drugs Private Limited, with revenue of ₹25.06 Cr (FY 2024).
Ashwin Kumar Veeramally currently holds positions at 1 company: Sri Pranava Gayathri Drugs Private Limited (₹25.06 Cr).